C-peptide decline in type 1 diabetes has two phases: An initial exponential fall and a subsequent stable phase
Diabetes Care Jun 15, 2018
Shields BM, et al. - Researchers explored the link between log-transformed C-peptide levels and the duration of diabetes up to 40 years after diagnosis. Using nonlinear regression approaches, the pattern of connection between urinary C-peptide/creatinine ratio (UCPCR) and duration of diabetes in cross-sectional data from 1,549 people with type 1 diabetes was evaluated. The results obtained from the study supported two clear phases of C-peptide decline: an initial exponential fall over a 7-year period, followed by a prolonged stabilization where C-peptide levels no longer decline. Between these two phases, understanding the pathophysiological and immunological differences will give crucial insights into understanding β-cell survival.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries